Karius
About
Karius provides advanced infectious disease diagnostics by leveraging clinical metagenomics and AI to detect microbial cell-free DNA. Their core products, Karius Spectrum™ and Karius Focus™ | BAL, offer rapid and comprehensive pathogen detection for systemic and lung infections, respectively. Karius serves patients and healthcare providers by enabling clear and timely diagnoses for difficult-to-diagnose infections.
Key facts
At-a-glance profile data
- Website
- kariusdx.com
- Founded
- 2014
- Employees
- 214
- Total funding
- $315M (Series C)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 6 May 2024 | Series C | $100M | 5AM Ventures, Glide Healthcare, Nabeel Quryshi |
| 24 Feb 2020 | Series B | $165M | Softbank |
| 7 Aug 2017 | Series A | $50M | Lightspeed Venture Partners, DCVC Bio |
Tech stack
Detected on kariusdx.com, last scanned 21 Sept 2026. Run your own scan
- Frontend
- Next.js
- Analytics
- Hotjar
- Support
- HubSpot
- CMS / Builders
- Ghost
- CDN
- Vercel
- Email provider
- Mimecast
- Email marketing
- HubSpot Forms, Salesforce Pardot
Add first review
Frequently asked
How much funding has Karius raised?
Karius has raised a total of $315M in funding. The most recent round on record is Series C.
How many employees does Karius have?
Karius has approximately 214 people on record.